Overview of superdisintegrants

GENERAL INTRODUCTION OF SUPERDISINTERGRANTS 

Superdisintegrants are essential components in solid dosage forms, especially tablets and capsules. These excipients are specifically designed to promote rapid and efficient disintegration of drug products. The main roles of superdisintegrants include:

• Improving tablet disintegration: They help break down the tablet structure upon contact with gastrointestinal fluids.
• Increasing solubility, dissolution rate, and bioavailability of active pharmaceutical ingredients (APIs): This is particularly important for poorly soluble APIs.

To effectively perform their functions, superdisintegrants need to possess the following properties, depending on the dosage form, API, and manufacturing process used:

• Rapid disintegration at low usage concentrations.
• Good flowability (for tablets manufactured by direct compression).
• Good compressibility, allowing for tablets with high hardness and low friability (for tablets).
• Good wetting ability for the active substance.
• No incompatibility with ionic substances (in cases where the API/excipients in the formulation are in ionic form).
• No impact on the drug release profile (for modified-release tablets).
• No change in water absorption and swelling capacity when the environmental pH changes.

APPLICATION OF LIPID-BASED EXCIPIENTS IN PHARMACEUTICAL FORMULATION & MANUFACTURING

Typically, superdisintegrants primarily function through three mechanisms: swelling, wicking, and shape recovery.

Most current superdisintegrants are a combination of the aforementioned mechanisms, acting to varying degrees.

COMMON SUPERDISINTERGRANTS

Sodium Starch Glycolate: cross-linked sodium salt of carboxymethyl starch

• Has strong swelling capacity, especially grades produced from potato starch (swells 200 times its original volume).
• Suitable for poorly soluble active ingredients.
• Swelling leads to gel formation, therefore, if used in quantities > 8% in the formulation, there is a risk of affecting tablet disintegration and drug release.
• Recommended usage level: 2 – 8%.

Croscarmellose Sodium: cross-linked carmellose sodium

• Combines two mechanisms: swelling and wicking.
• Suitable for tablets containing soluble or insoluble components.
• A commonly used superdisintegrant; recommended usage level: 1 – 4%.

Crospovidone (PVPP): N-vinylpyrrolidone derivative

• Disintegrates tablets via all three mechanisms: swelling, wicking, and recovery.
• Non-ionizing superdisintegrant; does not cause incompatibility with ionic active ingredients.
• Does not form a gel even at high concentrations of 10%.
• Does not change water absorption and swelling capacity when environmental pH changes.
• Recommended usage level: 1 – 4%.
• Available in two grades with different particle sizes, XL and XL-10, suitable for various applications.

Polacrillin Potassium:

• Disintegrates tablets via all three mechanisms: swelling, wicking, and recovery.
• High swelling capacity; does not form a gel.
• Non-ionizing superdisintegrant; does not cause incompatibility with ionic active ingredients.
• Disintegrates into fine particles, thereby increasing the dissolution rate and bioavailability for the active ingredient.

In summary, superdisintegrants play an indispensable role in modern pharmaceutical formulation and manufacturing. Thanks to their ability to promote rapid tablet disintegration, they significantly improve the dissolution rate and bioavailability of active pharmaceutical ingredients, which is especially crucial for drugs requiring a fast onset of action or those with poor solubility. The selection and optimization of superdisintegrants are key factors in creating pharmaceutical products that not only meet quality standards but also deliver optimal therapeutic efficacy for patients. Therefore, the role of superdisintegrants will increasingly be emphasized in the development of the pharmaceutical industry.